ACCESSION: MSBNK-SMB_Measured-HSA015P0357001
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.03.05 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.05, Curated 2025.03.05)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 18
COMMENT: RAW_SPEC {'EL02_pos_2109': {'bp': 150596.0, 'sum': 575461.0}, 'EL22_pos_2115': {'bp': 124624.0, 'sum': 484387.0}, 'EL01_pos_2102': {'bp': 111632.0, 'sum': 436091.0}, 'EL20_pos_2097': {'bp': 110064.0, 'sum': 406709.0}, 'EL08_pos_2104': {'bp': 108517.0, 'sum': 438969.0}, 'EL18_pos_2103': {'bp': 107232.0, 'sum': 414858.0}, 'EL17_pos_2097': {'bp': 106988.0, 'sum': 417522.0}, 'EL14_pos_2103': {'bp': 101339.0, 'sum': 424427.0}, 'EL13_pos_2105': {'bp': 88532.0, 'sum': 334607.0}, 'EL12_pos_2105': {'bp': 84967.0, 'sum': 328191.0}, 'EL21_pos_2097': {'bp': 79962.0, 'sum': 331394.0}, 'EL23_pos_2105': {'bp': 79789.0, 'sum': 301801.0}, 'EL15_pos_2105': {'bp': 78128.0, 'sum': 281540.0}, 'EL10_pos_2103': {'bp': 72091.0, 'sum': 283953.0}, 'EL04_pos_2109': {'bp': 68716.0, 'sum': 264293.0}, 'EL19_pos_2115': {'bp': 63660.0, 'sum': 286048.0}, 'EL11_pos_2110': {'bp': 55566.0, 'sum': 211434.0}, 'EL09_pos_2122': {'bp': 32867.0, 'sum': 128894.0}}
COMMENT: RETENTION_TIME_STDEV 0.009
COMMENT: PRECURSOR_M/Z_RAW 357.175032
COMMENT: PRECURSOR_M/Z_STDEV 0.000113
COMMENT: PRECURSOR_IN_MS1 mz 357.175015; int 64.342; delta(ppm) 1.190518
COMMENT: PROPOSED_CHARGE_STATE +1; mz 358.177548; int 13.034; cor 0.872
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 4.647; C25H25P; [M+H]+; delta(ppm) -4.646687
COMMENT: PROPOSED_MF SevenGoldenRules 1.449; C14H28O10; [M+H]+; delta(ppm) -1.448756
COMMENT: PROPOSED_MF SevenGoldenRules 2.010; C18H30O3P2; [M+H]+; delta(ppm) 2.010289
COMMENT: PROPOSED_MF MS-FINDER 2.718; C19H24N4OS; [M+H]+; delta(ppm) 1.814662
COMMENT: PROPOSED_MF MS-FINDER 2.575; C10H34N2O5P2S; [M+H]+; delta(ppm) 3.828274
COMMENT: PROPOSED_MF MS-FINDER 2.369; C11H20N10O4; [M+H]+; delta(ppm) 2.327627
COMMENT: PROPOSED_MF MS-FINDER 2.306; C11H28N6O3S2; [M+H]+; delta(ppm) 3.639026
COMMENT: PROPOSED_MF MS-FINDER 2.304; C9H33N4O4PS2; [M+H]+; delta(ppm) -0.985516
COMMENT: PROPOSED_MF MS-FINDER 2.293; C14H28O10; [M+H]+; delta(ppm) -1.446194
COMMENT: PROPOSED_MF MS-FINDER 2.019; C9H25N8O5P; [M+H]+; delta(ppm) -2.296904
COMMENT: PROPOSED_MF MS-FINDER 1.999; C12H16N14; [M+H]+; delta(ppm) -1.416799
COMMENT: PROPOSED_MF MS-FINDER 1.911; C17H29N2O2PS; [M+H]+; delta(ppm) -2.809863
COMMENT: PROPOSED_MF MS-FINDER 1.879; C15H32O5S2; [M+H]+; delta(ppm) -3.879211
COMMENT: PROPOSED_MF MS-FINDER 1.855; C19H32S3; [M+H]+; delta(ppm) 3.126061
COMMENT: PROPOSED_MF MS-FINDER 1.764; C11H36N2O2S4; [M+H]+; delta(ppm) 4.950429
COMMENT: PROPOSED_MF SIRIUS5_Sirius 41.797; C15H24N4O6; [M+H]+; delta(ppm) -5.190591
COMMENT: PROPOSED_MF SIRIUS5_Sirius 36.669; C19H21FN4O2; [M+H]+; delta(ppm) 8.053889
COMMENT: PROPOSED_MF SIRIUS5_Sirius 29.891; C18H23F3N2O2; [M+H]+; delta(ppm) -9.607031
COMMENT: PROPOSED_MF SIRIUS5_Sirius 24.105; C19H24N4OS; [M+H]+; delta(ppm) 1.814662
COMMENT: PROPOSED_MF SIRIUS5_Sirius 18.452; C21H22F2N2O; [M+H]+; delta(ppm) -6.407939
COMMENT: PROPOSED_MF SIRIUS5_Sirius 8.258; C18H28O5S; [M+H]+; delta(ppm) 5.559112
COMMENT: PROPOSED_MF SIRIUS5_Sirius 0.946; C21H25ClN2O; [M+H]+; delta(ppm) -62957.823175
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.997; C15H24N4O6; [M+H]+; delta(ppm) -5.190591
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.003; C19H21FN4O2; [M+H]+; delta(ppm) 8.053889
COMMENT: PROPOSED_MF SIRIUS6_Sirius 75.490; C15H32O5S2; [M+H]+; delta(ppm) -3.879211
COMMENT: PROPOSED_MF SIRIUS6_Sirius 70.994; C16H31ClFO3P; [M+H]+; delta(ppm) -62964.692685
COMMENT: PROPOSED_MF SIRIUS6_Sirius 69.563; C14H28O10; [M+H]+; delta(ppm) -1.446194
COMMENT: PROPOSED_MF SIRIUS6_Sirius 68.403; C14H30BCl2NO4; [M+H]+; delta(ppm) -37685.542505
COMMENT: PROPOSED_MF SIRIUS6_Sirius 66.756; C15H29FO6S; [M+H]+; delta(ppm) 2.359944
COMMENT: PROPOSED_MF SIRIUS6_Sirius 66.590; C16H32O3Si3; [M+H]+; delta(ppm) -151839.720510
COMMENT: PROPOSED_MF SIRIUS6_Sirius 66.301; C13H30N3O4S2; [M+H]+; delta(ppm) -0.120107
COMMENT: PROPOSED_MF SIRIUS6_Sirius 65.567; C11H28N6O3S2; [M+H]+; delta(ppm) 3.639026
COMMENT: PROPOSED_MF SIRIUS6_Sirius 64.239; C15H27ClF2N2O3; [M+H]+; delta(ppm) -62963.441143
COMMENT: PROPOSED_MF SIRIUS6_Sirius 63.903; C18H24F2NO4; [M+H]+; delta(ppm) 1.095562
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.999; C15H32O5S2; [M+H]+; delta(ppm) -3.879211
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.001; C16H31ClFO3P; [M+H]+; delta(ppm) -62964.692685
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.001; C14H28O10; [M+H]+; delta(ppm) -1.446194
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; QZDVELJTPJLQCK-FICMELLKNA-N; [M+H]+; CC1(C)[C@H]2C[C@@H](Cl)[C@](C)([C@H]3CO3)[C@H](N=C)[C@H]2C2=CNC3=CC=CC1=C23
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; VOUIYZULMOEQEV-UHFFFAOYSA-N; [M+H]+; O=C(OCC1N2CCC(C1)C(C2)CC)NC3=CC=CC(=C3)C(F)(F)F
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; KSPHQLJUVYASFE-UHFFFAOYSA-N; [M+H]+; O=C1C2=CC(=CC=C2OC3CN(CCC(C)C)CC3N1C)C(F)(F)F
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; GUWBUYNLHLKYRH-UHFFFAOYSA-N; [M+H]+; O=C(N)CCNC(=O)C1=CC(NC(=O)C2NCC(O)C2)C(O)C(O)C1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; BATSWSYTXABJAO-UHFFFAOYSA-N; [M+H]+; O=C(NC(C(=O)N)C)C1=CC(NC(=O)C2NCC(O)C2)C(O)C(O)C1
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.339; PAGABLYKRXWUAB-UHFFFAOYSA-N; [M+H]+; 4-(2-{[methyl(prop-2-yn-1-yl)amino]methyl}-1,3-thiazol-4-yl)-1-[(pyridin-2-yl)methyl]piperidin-4-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.225; RTDIDWVVPJYUCA-UHFFFAOYSA-N; [M+H]+; 1-[1-ethyl-6-methyl-4-(4-phenyl-1-piperazinyl)-2-sulfanylidene-5-pyrimidinyl]ethanone
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.199; JSHYXJSVGRKFHL-UHFFFAOYSA-N; [M+H]+; N-({5-[2-methyl-6-(thiophen-2-yl)pyrimidin-4-yl]-1-azabicyclo[2.2.2]octan-2-yl}methyl)acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -280.704; TVRCRTJYMVTEFS; [M+H]+; Valopicitabine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -318.045; GUWBUYNLHLKYRH; [M+H]+; N-[3-[(3-amino-3-oxopropyl)carbamoyl]-5,6-dihydroxycyclohex-2-en-1-yl]-4-hydroxypyrrolidine-2-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -330.986; BATSWSYTXABJAO; [M+H]+; N-[3-[(1-amino-1-oxopropan-2-yl)carbamoyl]-5,6-dihydroxycyclohex-2-en-1-yl]-4-hydroxypyrrolidine-2-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.093; TVRCRTJYMVTEFS; [M+H]+; Valopicitabine
COMMENT: CONFIDENCE Level 5: Exact mass of interest 357.175007; Observed in MS1; Charge state +1;
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 Âµm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 3.400
MS$FOCUSED_ION: PRECURSOR_M/Z 357.175007
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-014r-0910000000-59f9334d613d7c9fe5e1
PK$ANNOTATION: m/z int annotation m/z_nocal m/z_std(ppm) int_std cor n
  80.9450973 83.7401 ? 80.945824 0.8030 15.99 1.0000 17
  98.9555571 81.1284 ? 98.956179 1.1419 15.72 0.6500 16
  114.9706929 40.2801 ? 114.971177 1.5221 10.01 0.6308 15
  115.9699881 85.5057 ? 115.970463 1.1727 15.95 0.9029 17
  116.9662126 839.5510 ? 116.966679 0.3933 60.80 0.9093 18
  117.9661009 56.6934 ? 117.966559 1.1274 9.80 0.8088 18
  128.9662023 48.9285 ? 128.966549 1.1864 9.40 0.6964 16
  167.0181815 295.3891 ? 167.018530 0.8981 24.29 0.8088 17
  183.0332960 46.0255 ? 183.033692 1.1200 7.46 0.8945 15
  184.0327353 109.0043 ? 184.033134 1.2172 12.82 0.7143 16
  185.0287796 999.0000 ? 185.029182 0.3459 0.00 0.8529 18
  197.0288011 83.5921 ? 197.029241 1.4262 9.87 0.7934 15
  203.0393358 70.6268 ? 203.039779 0.9358 15.08 0.7357 16
  253.0914911 238.0807 ? 253.091862 0.8060 24.00 0.8799 18
  271.1018060 124.0660 ? 271.102193 1.5714 18.55 0.8652 18
PK$NUM_PEAK: 15
PK$PEAK: m/z int. rel.int.
  80.945097 83.74 83
  98.955557 81.13 81
  114.970693 40.28 40
  115.969988 85.51 85
  116.966213 839.55 839
  117.966101 56.69 56
  128.966202 48.93 48
  167.018181 295.39 295
  183.033296 46.03 46
  184.032735 109.00 109
  185.028780 999.00 999
  197.028801 83.59 83
  203.039336 70.63 70
  253.091491 238.08 238
  271.101806 124.07 124
//
